CrossrefInfokarte
Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Gastroenterology Research · 2024-08 · 17 (4) · 159-174
DOI: 10.14740/gr1750 ↗Abstract
Kein Abstract verfügbar.
EUVIMED